Related Experiment Video
Updated: Jun 5, 2025
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection
Wenhao Li1, Zhihao Wang1, Siliang Chen1
1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
Abstract:
Glioblastoma (GBM) is a highly malignant tumor of the central nervous system that remains intractable despite advancements in current tumor treatment modalities, including immunotherapy. In recent years, metabolic checkpoints (aberrant metabolic pathways underlying the immunosuppressive tumor microenvironment) have gained attention as promising therapeutic targets and sensitive biomarkers across various cancers. Here, we briefly review the existing understanding of tumor metabolic checkpoints and their implications in the biology and management of GBM. Additionally, we discuss techniques that could evaluate metabolic checkpoints of GBM non-invasively, thereby potentially facilitating neo-adjuvant treatment and dynamic surveillance.
Insights
Metabolic checkpoints offer new therapeutic targets for glioblastoma (GBM), a challenging brain tumor. Non-invasive techniques may enable better treatment and monitoring of GBM.
Area of Science:
- Neuro-oncology
- Cancer Metabolism
- Immunotherapy
Background:
- Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options.
- The tumor microenvironment in GBM often suppresses anti-tumor immunity.
- Metabolic checkpoints, altered metabolic pathways in cancer, are emerging as key factors in tumor biology.
Purpose of the Study:
- To review the current understanding of metabolic checkpoints in glioblastoma.
- To explore the implications of metabolic checkpoints in GBM biology and treatment.
- To discuss non-invasive methods for evaluating GBM metabolic checkpoints.
Main Methods:
- Literature review of metabolic checkpoints in cancer and glioblastoma.
- Analysis of the role of metabolic pathways in the GBM tumor microenvironment.
- Discussion of imaging and biomarker techniques for metabolic assessment.
Main Results:
- Metabolic checkpoints are crucial in shaping the immunosuppressive GBM microenvironment.
- Aberrant metabolism in GBM presents potential therapeutic vulnerabilities.
- Non-invasive evaluation techniques could aid in treatment planning and monitoring.
Conclusions:
- Targeting metabolic checkpoints represents a promising strategy for GBM therapy.
- Understanding GBM metabolic checkpoints is vital for improving patient outcomes.
- Non-invasive assessment of metabolic checkpoints could revolutionize GBM management.
